Elevance Health Inc [ELV] stock is trading at $396.49, up 4.02%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELV shares have gain 6.71% over the last week, with a monthly amount glided 1.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on October 18, 2024, when Argus downgraded its rating to a Hold. Previously, BofA Securities downgraded its rating to Neutral on July 18, 2024, and dropped its price target to $530. On June 24, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $643 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $649 on May 30, 2024. Barclays initiated its recommendation with a Overweight and recommended $584 as its price target on March 06, 2024. Wolfe Research downgraded its rating to Peer Perform for this stock on July 12, 2023. In a note dated April 27, 2023, Morgan Stanley upgraded an Overweight rating on this stock and boosted its target price from $500 to $571.
Elevance Health Inc [ELV] stock has fluctuated between $362.21 and $567.26 over the past year. Currently, Wall Street analysts expect the stock to reach $525.33 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $396.49 at the most recent close of the market. An investor can expect a potential return of 32.5% based on the average ELV price forecast.
Analyzing the ELV fundamentals
Elevance Health Inc [NYSE:ELV] reported sales of 174.01B for the trailing twelve months, which represents a growth of 5.36%. Gross Profit Margin for this corporation currently stands at 0.28% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.15 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 385.62 points at the first support level, and at 374.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 402.89, and for the 2nd resistance point, it is at 409.30.
Ratios To Look Out For
For context, Elevance Health Inc’s Current Ratio is 1.50. Considering the valuation of this stock, the price to sales ratio is 0.53, the price to book ratio is 2.10 and price to earnings (TTM) ratio is 14.45.
Transactions by insiders
Recent insider trading involved Kendrick Charles Morgan JR, EVP & President, Commercial, that happened on Oct 18 ’24 when 7417.0 shares were sold. Director, Kendrick Charles Morgan JR completed a deal on Oct 18 ’24 to buy 7417.0 shares. Meanwhile, Director PERU RAMIRO G sold 753.0 shares on Aug 05 ’24.
